CH654743A5 - Pharmaceutical composition with antiulcer, spasmolytic and local anaesthetic action - Google Patents

Pharmaceutical composition with antiulcer, spasmolytic and local anaesthetic action Download PDF

Info

Publication number
CH654743A5
CH654743A5 CH4782/83A CH478283A CH654743A5 CH 654743 A5 CH654743 A5 CH 654743A5 CH 4782/83 A CH4782/83 A CH 4782/83A CH 478283 A CH478283 A CH 478283A CH 654743 A5 CH654743 A5 CH 654743A5
Authority
CH
Switzerland
Prior art keywords
spasmolytic
pharmaceutical composition
antiulcer
active ingredient
antacid
Prior art date
Application number
CH4782/83A
Other languages
German (de)
English (en)
Inventor
Ludek Benes
Anna Babulova
Viera Nosalova
Svorad Stolc
Alois Borovansky
Viktor Bauer
Original Assignee
Slovenska Akademia Vied
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Slovenska Akademia Vied filed Critical Slovenska Akademia Vied
Publication of CH654743A5 publication Critical patent/CH654743A5/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/08—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
    • C07D295/096—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/27—Esters, e.g. nitroglycerine, selenocyanates of carbamic or thiocarbamic acids, meprobamate, carbachol, neostigmine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Emergency Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
CH4782/83A 1983-09-13 1983-08-31 Pharmaceutical composition with antiulcer, spasmolytic and local anaesthetic action CH654743A5 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19833333008 DE3333008A1 (de) 1983-09-13 1983-09-13 Pharmazeutische mittel mit antiulceroeser, spasmolytischer und lokalanaesthetischer wirkung

Publications (1)

Publication Number Publication Date
CH654743A5 true CH654743A5 (en) 1986-03-14

Family

ID=6208945

Family Applications (1)

Application Number Title Priority Date Filing Date
CH4782/83A CH654743A5 (en) 1983-09-13 1983-08-31 Pharmaceutical composition with antiulcer, spasmolytic and local anaesthetic action

Country Status (6)

Country Link
JP (1) JPS6067421A (fr)
BE (1) BE897823A (fr)
CH (1) CH654743A5 (fr)
DE (1) DE3333008A1 (fr)
NL (1) NL8303098A (fr)
SE (1) SE462420B (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6103380A (en) 1998-06-03 2000-08-15 Cabot Corporation Particle having an attached halide group and methods of making the same

Also Published As

Publication number Publication date
SE8304818L (sv) 1985-03-09
JPS6067421A (ja) 1985-04-17
DE3333008A1 (de) 1985-03-21
SE462420B (sv) 1990-06-25
NL8303098A (nl) 1985-04-01
JPH045003B2 (fr) 1992-01-30
SE8304818D0 (sv) 1983-09-08
BE897823A (fr) 1984-01-16
DE3333008C2 (fr) 1990-06-21

Similar Documents

Publication Publication Date Title
DE19541128C2 (de) Stabilisierte schilddrüsenhormonhaltige Arzneimittel
DE69623634T2 (de) Pharmazeutische zusammensetzung von l-dopa ethyl ester
DE69218557T2 (de) Stabile Zusammensetzung die ein Enalapril-Salz enthält, Verfahren zu ihrer Herstellung und ihre Verwendung
EP0193056B1 (fr) Combinaison de la flupirtine avec des spasmolytiques à effet anticholinergique
DE2523998A1 (de) Pharmazeutische zubereitung fuer die behandlung der schizophrenie
DE69721756T2 (de) Paroxetine zur behandlung von depression
DE3604575A1 (de) Kombination von flupirtin und anticholinergisch wirkenden spasmolytika
EP0476113B1 (fr) Medicament pour le traitement de l'hyperlipemie et/ou de l'atherosclerose
DE69328792T2 (de) Behandlung von migräne
DE3779842T2 (de) Antiallergisches mittel.
CH621333A5 (fr)
DE3035494A1 (de) Carnitin enthaltendes arzneimittel zur behandlung von hyperlipidaemie und hyperlipoproteinaemie, sowie verwendung von carnitin zur herstellung eines solchen arzneimittels
CH654743A5 (en) Pharmaceutical composition with antiulcer, spasmolytic and local anaesthetic action
DE69121058T2 (de) Salze von Glykosaminoglykanen mit Aminosäureester, ihre Herstellung sowie sie enthaltende pharmazeutische Zusammensetzungen
DE2748291A1 (de) Triglyceride, verfahren zu ihrer herstellung und ihre verwendung zur behandlung von entzuendungen
CH655243A5 (de) Arzneimittelkombination und verfahren zu ihrer herstellung.
DE68905424T2 (de) Alpha-glucosidaseinhibitor zur foerderung der calciumabsorption.
DE3027056A1 (de) Pharmazeutischer ansatz zur verwendung als schutz gegen akutes lungenoedem, anaphylaktischen schock u.a. arten von schock sowie hyperfibrinolyse
DE69426317T2 (de) Verwendung von Beta-Naphthochinonderivaten zur Hemmung von Blutplättchen-Aggregation
DE2059620A1 (de) Neuartige Aminoaethansulfonsaeurederivate
DE2413803A1 (de) Pharmazeutische zusammensetzungen aus gemischten salzen von sulfoglykopeptiden mit metallbasen und organischen basen
DE2143203A1 (de) Arzneimittel mit ulcusheilender wirkung
DE2532180C2 (de) Verwendung von Etozolin bei der Bekämpfung der Hypertonie
DE2823267A1 (de) Antihypertensive praeparate
EP1326588B1 (fr) Formes de preparations orales d'extraits de boswellia

Legal Events

Date Code Title Description
PL Patent ceased